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Available online 25 September 2004Abstract—The structure and bioactivity of a polysaccharide extracted and puriﬁed from a 4M KOH + H3BO3 solution from Prunus
dulcis seed cell wall material was studied. Anion-exchange chromatography of the crude extract yielded two sugar-rich fractions: one
neutral (A), the other acidic (E). These fractions contain a very similar monosaccharide composition: 5:2:1 for arabinose, uronic
acids and xylose, respectively, rhamnose and galactose being present in smaller amounts. As estimated by size-exclusion chromato-
graphy, the acidic fraction had an apparent molecular mass of 762kDa. Methylation analysis (from the crude and fractions A and
E), suggests that the polysaccharide is an arabinan-rich pectin. In all cases, the polysaccharides bear the same type of structural Ara
moieties with highly branched arabinan-rich pectic polysaccharides. The average relative proportions of the arabinosyl linkages is
3:2:1:1 for T-Araf:(1!5)-Araf:(1!3,5)-Araf:(1!2,3,5)-Araf. The crude polysaccharide extract and fractions A and E induced a
murine lymphocyte stimulatory eﬀect, as evaluated by the in vitro and in vivo expression of lymphocyte activation markers and
spleen mononuclear cells culture proliferation. The lymphocyte stimulatory eﬀect was stronger on B- than on T-cells. No evidence
of cytotoxic eﬀects induced by the polysaccharide fractions was found.
 2004 Elsevier Ltd. All rights reserved.
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From birth, living systems are continually exposed to a
variety of microorganisms that have the potential to
cause disease and death. In vertebrates, protection from
pathogenic microorganisms is achieved by a complex ar-
ray of defensive mechanisms collectively termed the im-
mune system.1,2 These same immune mechanisms, which
eﬃciently eliminate pathogens, pose a potential threat to0008-6215/$ - see front matter  2004 Elsevier Ltd. All rights reserved.
doi:10.1016/j.carres.2004.07.024
* Corresponding author. Tel.: +351 253 604400; fax: +351 253 678986;
e-mail: fmgama@deb.uminho.ptthe host that must thus ensure immune tolerance to the
somatic self.3 When immune control mechanisms fail,
infectious or autoimmune pathology ensues, and agents
capable of improving defence or regulatory immune re-
sponses are potentially helpful. Compounds that are
capable of interacting with the immune system to upreg-
ulate or downregulate speciﬁc aspects of the host re-
sponse can be classiﬁed as immunomodulators or
biologic response modiﬁers.4
In recent years, plant polysaccharides have emerged
as an important class of bioactive natural products. A
wide range of polysaccharides has been reported to exhi-
bit a variety of immunological activities: anti-tumour,5
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Figure 1. Elution proﬁle of the crude extract on DEAE Sepharose Fast
Flow. The crude extract (1g) was dissolved overnight in 1L 0.1M
NaOH and applied to the column. Neutral polysaccharides where
2556 F. Dourado et al. / Carbohydrate Research 339 (2004) 2555–2566immunostimulatory,6–9 anti-complementary,10–12 anti-
inﬂammatory,13 anti-coagulant and ﬁbrinogenic.14
Almond seeds are typically used in a variety of proc-
essed foods, notably in bakery and confectionery prod-
ucts.15 With 16–22% (w/w, dry weight) protein, except
for methionine, almonds contain all the essential amino
acids (g essential aminoacids/100g protein) in quantities
equal or greater than those recommended by the FAO
guidelines.16,17 The seeds high oil content (around
50%, w/w), with oleic and linoleic acids as the major
constituents,18,19 makes it a valuable product in the
human diet and cosmetics.
This paper describes the isolation and structural char-
acterisation of an arabinan-rich pectic polysaccharide
obtained from the Prunus dulcis cell wall material
(CWM) by extraction with a 4M KOH + H3BO3 solu-
tion. Moreover, based on previously reported evidence
of immune activities of polysaccharides of microbial
(reviewed in Ref. 4) or plant origin,20–28 a possible
immunomodulatory eﬀect of the arabinan-rich pectin
was studied in murine models.
eluted with 0.1M NaOH, and the acidic fractions were eluted with a
linear gradient of NaCl (0–1M in the same alkaline solution).
Fractions were collected and monitored by the phenol–H2SO4 method.
(––) Total carbohydrates; (- - -) NaCl gradient.2. Experimental
A mixture containing several regional varieties (Bojuda,
Ferradouro, Foˆfana, Grada, Jose´ Dias, Ludo, Molar da
Fuseta) of dehulled almond seeds was supplied from the
region of Alfaˆndega da Fe´ (Braganc¸a, Portugal). The
cell-wall material (CWM) was prepared and sequentially
extracted with imidazole, Na2CO3 and KOH solutions
(0.5 and 1M at 4 C, 1, 4M, 4M + H3BO3, 8M at
20 C) as described in Dourado et al.29 The crude extract
from the 4M KOH + H3BO3 treatment was used in the
present work. Preliminary immunobiological activity as-
says were conducted with the crude extract. This extract
exhibited a lymphocyte stimulatory activity and was thus
further puriﬁed and characterised in the present work.
2.1. Isolation and structure characterisation of a poly-
saccharide from almond CWM
2.1.1. Anion-exchange chromatography. The crude ex-
tract (1g) was dissolved overnight in 1L of 0.1M
NaOH, at room temperature. The solution was passed
through a 50 · 460-mm DEAE Sepharose Fast Flow
packed column (2.7lmol uronic acid/mL resin) in the
chloride form, at a ﬂow rate of 0.7mL/min. The neutral
polysaccharides were eluted at room temperature with a
0.1M NaOH solution (1.5L) and the acidic fractions
were eluted with a linear gradient of NaCl (0–1M in
the same alkaline solution; 1.5L).
Fractions of 10mL were collected and assayed for
total carbohydrates by the phenol–H2SO4 method.
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The sugar-rich fractions (A, B, C, D, E; Fig. 1) were
pooled, dialysed against distilled water and freeze dried.2.1.2. Elemental analysis. The crude extract and frac-
tions A and E were tested for nitrogen (N) contamina-
tion, by the ICP (Inductively Coupled Plasma)
technique and by LSM (Light Scanning Microscopy).
ICP was done at IAREN-Instituto da A´gua da Regia˜o
do Norte (Portugal) using a Varian model Liberty AX.
LSM was done using a Leica Cambrigge S-360 cou-
pled with a Microanalysis System by energy dispersion
spectrometry (EDX)-Link eXL II. Samples were cov-
ered with gold by magnetron sputtering.
In all fractions analysed, nitrogen was not detected by
these two methods.
2.1.3. Size-exclusion chromatography. The crude ex-
tract, fractions A and E (500lL, at a concentration of
1mg/mL) were injected into a 9 · 500mm Sephacryl
S-400 HR packed column (the useful fractionation
range for dextrans is 10–2000kDa, according to Phar-
macia–Biotech). Size exclusion was run with a ﬂow rate
of 0.7mL/min, at room temperature, using 0.1M NaOH
as eluent. Fractions of 1.5mL were collected and ana-
lysed for total carbohydrates by the phenol–H2SO4
method.30
Calibration of the column was done using dextran
standards (all from Sigma) with average molecular
masses of 10, 40, 70, 526kDa. The void volume was esti-
mated with Blue Dextran (2000kDa).
2.1.4. Dynamic light scattering. Samples from fraction
A and E (1mg/mL, weighted) were dissolved in water
F. Dourado et al. / Carbohydrate Research 339 (2004) 2555–2566 2557and 0.1M NaOH. The samples were centrifuged for
5min at 10,000g and analysed with a Protein Solutions
Dynapro MS instrument using the DINAMICS software.
Calibration was done using dextran standards (all from
Sigma) with average molecular masses of 10, 40, 70,
526kDa.
2.1.5. Quantitative determination of monosaccharides and
uronic acids. Neutral sugars, released by Saeman
hydrolysis,31 were analysed as their alditol acetates by
gas–liquid chromatography in a Carlo Erba GC 6000
series 2, with a FID detector and a DB 225 column.
The injector and detector temperature were at 220 and
230 C, respectively. Following injection (approximately
2lL) of the sample, the oven was maintained at 220 C
for 5min, followed by a temperature rise of 5 Cmin1,
until 230 C. This temperature was maintained for 6min.
Hydrogen was used as a carrier gas at 78Pa, and 2-
deoxy-glucose (2-deoxy-D-arabinose-hexose) was used
as internal standard.
Methylation and carboxyl reduction of the poly-
saccharides from the crude extract and from fractions
A and E was carried out following the Ciucanu and
Kerek,32 Isogai et al.33 and Lindberg and Lo¨nngren34
procedures, as described by Coimbra et al.35
2.1.6. Methylation procedure. The sample (2–3mg) was
weighed into glass tubes and placed in a vacuum oven,
at 40 C, overnight in the presence of P2O5 (s). After-
wards it was dispersed in 2mL of anhyd Me2SO and
sonicated occasionally until it was fully dispersed.
NaOH pellets (100mg) powdered under argon were
added to the solution. The sample was sonicated for
90min and allowed to stand for another 90min. The
solution was cooled in an ice bath, and then 1mL of cold
methyl iodide was added. The mixture was allowed to
react for 30min in an ultrasonic bath and left standing
for another 30min. Three mL of 1:1 CHCl3–MeOH
were added, and the solution was dialysed against three
lots of 50% EtOH. The material was then evaporated
and freeze dried.
This methylation procedure was repeated, and the
resulting material was dialysed. The solution obtained
was divided (2/3 of which was used for the reduction
of the carboxyl reduction of the methylated polysacchar-
ides) and freeze dried.
2.1.7. Hydrolysis, reduction and acetylation of the meth-
ylated polysaccharides. The methylated polysacchar-
ides were hydrolysed with 300lL of 2M TFA, at
121 C, for 1h,36 cooled and evaporated. The methylated
sugars were then suspended in 200lL of 2M NH3, and
20mg NaBD4 were added. The mixture was left reacting
at 30 C for 1h. The reaction was terminated by the
addition of 0.1mL of glacial HOAc. The acetylation
was done by adding 450lL of 1-methylimidazole and3mL of Ac2O and allowing the mixture to react for
30min, at 30 C. Then, 3mL of distilled water were
added to decompose the Ac2O, and the acetylated sug-
ars were extracted with 3–5mL of CH2Cl2. The organic
phase was washed three times with water and then evap-
orated to dryness.
2.1.8. Carboxyl reduction of methylated polysacchar-
ides. To the freeze-dried methylated material, 20mg of
LiAlD4 and 1mL anhyd THF were added and the mix-
ture was left to react for 4h, at 65 C. The reagent in
excess was eliminated by adding 2–3 drops of EtOH
and 2–3 drops of distilled water. The pH of the mixture
was reduced to neutrality by adding 2M H3PO4. Two
mL of 2:1 CHCl3–MeOH mixture were then added.
The reduced polymers were removed from the white
precipitate by centrifugation and washed thoroughly
with 2:1 CHCl3–MeOH. The supernatant collected was
evaporated, and the carboxyl-reduced material was
submitted to hydrolysis, reduction and acetylation, as
described above.
The partially methylated alditol acetates (PMAA)
were dissolved in 70lL of CH2Cl2, analysed by GC–
FID using a DB-1 capillary column, and characterised
by GC–MS. The samples were injected in the splitless
mode (time of splitless 0.75min), with the injector and
detector at 220 and 230 C, respectively. The following
temperature program was used: 45 C for 1min with a
linear increase of 45 Cmin1 up to 140 C, and standing
for 1min at this temperature, followed by a linear in-
crease of 0.5Cmin1 up to 170 C, with 1min further
at 170 C. Then, another linear increase of 45 Cmin1
up to 220 C, and standing for 5min at this temperature.
The linear velocity of the H2 carrier gas was set at
50cm/s at 218 C. The molar response factors of Sweet
et al.37 were used for the quantiﬁcation of the resolved
sugars.
GC–MS analysis was done on a Finigan Trace 2000
Series Chromatograph (Thermoquest CE Instruments)
equipped with a Finigan Trace MS. The chromato-
graphic conditions used were as described for GC–
FID. The linear velocity of the He carrier gas was set
at 1.8mL/min at 200 C, with a solvent delay of 4min.
2.2. Immunobiologic activity assay
2.2.1. Preparation of the polysaccharide extract. The
crude cell-wall extract obtained from the 4M
KOH + H3BO3 treatment and the fractions A and E,
obtained by anion-exchange chromatography, were used
for the assays. The solutions (ca. 1mg/mL, weighed)
were prepared by dispersing the polysaccharides in
50mM Tris–HCl Buﬀer + 1M NaCl. These samples
were then sterilised by ﬁltering through a 0.22-lm ﬁlter
(Whatman), and aliquots were collected and assayed for
total carbohydrates by the phenol–H2SO4 method.
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charide (LPS), the ﬁltered solutions were, under sterile
conditions, passed through a 5-mL Detoxigel column
(Pierce), previously washed several times with endo-
toxin-free water (25mL), 1% (w/v) deoxicolic acid solu-
tion (25mL), and then equilibrated with a solution
containing 50mM Tris–HCl Buﬀer + 1M NaCl. The
solutions were ﬁnally concentrated and washed several
times with endotoxin-free Phosphate Buﬀered Saline
(PBS) in an ultraﬁltration device (Centriplus, Amicon
Bioseparations, Millipore), to exchange buﬀers. Total
carbohydrates were also determined before and follow-
ing buﬀer exchange in order to estimate the loss of poly-
saccharide. No losses were detected following column
passage and buﬀer exchange.
2.2.2. Mice. Male C57BL/6 mice (6–8weeks old) were
purchased from Charles River (Barcelona, Spain), and
male C57BL/B10 ScCr mice (also 6–8weeks old) were
obtained from the Instituto Gulbenkian de Cieˆncia
(Oeiras, Portugal). All mice were kept at the animal
facilities of the Institute Abel Salazar, under speciﬁc
pathogen-free conditions until used. Sterile food and
water were supplied ad libitum.
2.2.3. In vitro mononuclear cell cultures of murine
mononuclear spleen cells. Spleen cells were obtained
by gently teasing the organ in RPMI-1640 medium (Sig-
ma, St. Louis, USA) supplemented with penicillin
(100IU/mL), streptomycin (50lg/mL), 2-mercapto-
ethanol (0.05M) and 10% of fetal bovine serum
(Sigma, St. Louis, USA) (RPMI) with or without
50lg/mL of polymixin B (Sigma, St. Louis, USA). To
isolate mononuclear cells, 5-mL aliquots of the spleen-
cell suspensions were layered onto 2.5 -mL aliquots of
a polysucrose/sodium ditrizoate solution (histopaque-
1083, Sigma Diagnostics, St. Louis, USA) and centri-
fuged at 110g for 20min, at room temperature. Cells
were then gently removed from the medium/histopaque
interface and then transferred to a sterile container and
washed with RPMI. Finally, the isolated mononuclear
cells were resuspended in 5mL of RPMI, and cell counts
were performed.
Mononuclear cell suspensions were distributed on 96-
well plates (5 · 105cells/well) and cultured for 6h or
3days at 37 C, in a 95% humidiﬁed atmosphere con-
taining 5% CO2. Plated cells were stimulated with med-
ium alone (negative control), 5lg/mL of LPS from
Salmonella abortus equi (Sigma, St. Louis), 5lg/mL of
concanavalin A (Sigma St. Louis) (Positive controls)
or with 250lg/mL of either crude extract, or fractions
A or E.
2.2.4. In vitro proliferation assays. In order to evaluate
polysaccharide-induced proliferation on mononuclear
cell cultures, the MTT proliferation assay was used.At the end of the incubation period, cell-culture super-
natants were replaced by an equal volume of an MTT
(methylthiazoletetrazolium; Sigma, St. Louis, USA)
solution (0.5mg of MTT/mL of Phenol red-free cell cul-
ture medium). Cells were further incubated for 4h, and
then the supernatants were decanted. A 0.08M HCl
solution in anhyd 2-propanol was added to each well
in an amount equal to the original culture volume for
dissolving the resulting MTT formazan crystals. The
optical density of the converted dye was measured at
570nm in a Multiskan Plate Reader (Multiskan EX,
Labsystem, Finland).
2.2.5. Macrophage cell cultures. Cell cultures of bone-
marrow-derived monocyte/macrophage cells were sus-
pended in Dulbecos modiﬁed Eagles medium (DMEM)
containing 10% of L929 cell-conditioned medium
(LCCM also in DMEM), in 24-well tissue culture plates
(0.5 · 106cells/well). The cells were incubated for 10days
at 37 C, in a 93% humidiﬁed atmosphere with 7% CO2.
On day 4, an additional volume of 100lL of LCCM was
added, and on day 7 the medium was removed and re-
placed again by fresh DMEM with 10% of LCCM.
After the 10th day of culture, when macrophage cells
were fully diﬀerentiated, crude extract was added to
the cell cultures at a ﬁnal concentration of 25, 250 or
2500lg/mL. Cultures stimulated with medium, 5lg/
mL of LPS from Salmonella abortus equi (Sigma, St
Louis) or the diﬀerent polysaccharide fractions were
incubated for 2, 6 and 24h. After those incubation peri-
ods cell-culture supernatants were collected for quantiﬁ-
cation of TNF or IL-10.
2.2.6. Macrophage cell-culture supernatants TNF and IL-
10 quantiﬁcation. IL-10 concentrations from macro-
phage cell-culture supernatants were determined with
the Quantikine M mouse IL-10 immunoassay kit
(R&D systems, Minneapolis, MN, USA), by following
the manufacturers instructions. TNF quantiﬁcation was
done by an ELISA capture assay. ELISA plates
(Maxisorp, Nunc, Roskilde, Denmark) were coated by
overnight incubation with 100lL/well of anti-mouse
TNF-a antibody (R&D systems, Germany), at a con-
centration of 0.8lg/mL. The wells were then saturated
for 1h at room temperature with 1% BSA in PBS. Undi-
luted cell culture supernatants and standard samples
were then plated and incubated for 2h at room temper-
ature. After washing, the bound TNF was detected by
addition of 100lL/well of biotinilated anti-TNF poly-
clonal antibody (R&D systems) at a 300ng/mL concen-
tration and incubated for 2h at room temperature.
Washed plates were further incubated for 20min with
100lL/well of peroxidase-coupled streptavidin. Sub-
strate solution containing tetramethylbenzidine and
H2O2 (R&D systems) was added to each well after
washing, and after a 20-min incubation the reaction
F. Dourado et al. / Carbohydrate Research 339 (2004) 2555–2566 2559was stopped adding 50lL of a solution containing 1M
H2SO4. Optical density readings were made at 450nm
in a Biotek Chromoscan ELISA plate reader.
2.2.7. Flow cytometry analysis. For cytometry analysis,
C57Bl/6 or C57BL/10 ScCr mice spleen cells were resus-
pended in balanced salt solution (BSS) supplemented
with 10mM of sodium azide and 1% bovine serum albu-
min (BSA). The following monoclonal antibodies were
used for immunoﬂuorescence cytometric analysis in a
FACScan (Becton Dickinson, San Jose, CA, USA): goat
anti-mouse IgM FITC conjugate (Southern Biotechno-
logy Associates, Birmingham, ALA, USA), hamster
anti-mouse CD3 FITC conjugate (Southern Biotechnol-
ogy Associates, Birmingham, ALA, USA), hamster anti-
mouse CD69 (PharMingen, San Diego, CA, USA) PE
conjugate or biotinilated rat anti-mouse CD25 (South-
ern Biotechnology Associates Birmingham, ALA,
USA). CELLQUEST software (Becton Dickinson) was
used to process the gathered data. Biotinilated anti-
mouse CD25 antibody was detected with PE-conjugated
avidin (Southern Biotechnology Associates Birming-
ham, ALA, USA). Dead cells were excluded by prop-
idium iodide incorporation.3. Results and discussion
3.1. Carbohydrate analysis
In the present work we characterised some structural
features of a CWM extract obtained with 4M
KOH + H3BO3. The main sugars of this crude extract
(Table 1) are Ara (52mol%), HexA (25mol%) and Xyl
(14mol%).
A viscous solution was obtained when the crude ex-
tract was dispersed in distilled water, in concentrationsTable 1. Monosaccharide composition of the crude extract and fractions ob
Flowa
Fraction Recovery (% w/w) Cell-wall
Rha Fuc Ara Xyl
Crude 3 Trb 52 14
Neutral anion exchange
A 10.6d 2 Tr 59 10
B 3.6 2 3 64 11
Acidic anion exchange
C 1.8 4 37 21 9
D 4.3 2 8 40 14
E 71.4 3 Tr 53 11
aNeutral fractions where eluted with 0.1M NaOH, and the acidic fractions w
solution).
b Tr = traces; HexA = hexuronic acid; blank spaces = not detected.
c Values are expressed as milligram anhydrosugar per gram.
d Value is expressed as %-crude extract.above 10mg/mL. This prevented fractionation of the
polysaccharides by graded ethanol precipitation (data
not shown). Despite of the observed viscous character,
rheological experiments (with concentrations ranging
from 10 to 30mg/mL, in water) showed that this solu-
tion does not display the characteristic behaviour of a
true gel (data not shown).
Anion-exchange chromatography experiments were
done by dispersing the crude extract in 50mM Tris–
HCl at a pH of 5.5 and 7.0, and in 0.1M NaOH, to a
ﬁnal concentration of 1mg/mL. At this concentration,
the solutions were not viscous. Each sample was then
fractionated on a DEAE Sepharose Fast Flow column.
For the 0.1M NaOH dispersed sample (Fig. 1), two neu-
tral (A and B) and three acidic fractions (C, D and E;
Table 1) were obtained. The recovery of the eluted mate-
rial was almost quantitative (92%). The essentially non-
carbohydrate material (10% of the crude extract) was
resolved in fractions B, C and D. Fractions A and E
are very rich in sugars, the acidic fraction E representing
ca. 70% of the crude extract. These fractions have a sim-
ilar sugar composition (and also similar to the crude ex-
tract), but fraction E could be eluted only with more
than 0.5M NaCl (Fig. 1). The crude extract was ob-
tained from P. dulcis CWM with a 4M KOH + H3BO3
treatment. Since alkaline solvents cause de-esteriﬁcation
of the polysaccharides acidic groups, it is unlikely that
the acidic residues from fraction A are esteriﬁed. As
these polysaccharides contain ca. 25% HexA (Table 1),
they should be negatively charged. However, they do
not interact with the DEAE matrix. In addition, com-
paring the elution proﬁles obtained using Tris–HCl
(pH5.5) buﬀer and NaOH solutions as eluents, it was
observed that, by increasing the pH, the recovery of
the acidic fractions increased by approximately ﬁve-fold
(data not shown). These observations suggest that,
even at high pH values, macromolecular aggregatestained by anion-exchange chromatography on DEAE Sepharose Fast
sugars (mol%) Total sugarsc (mgg1)
Man Gal Glc HexA
Tr 5 Tr 25 842
Tr 3 Tr 24 988
1 3 1 13 292
16 14 30
Tr 3 2 30 220
Tr 4 Tr 28 995
ere eluted with a linear gradient of NaCl (0–1M in the same alkaline
2560 F. Dourado et al. / Carbohydrate Research 339 (2004) 2555–2566are present in the aqueous crude extract solutions, being
eluted in the neutral fraction. The interaction between
the acidic groups of the polysaccharide and the charged
groups of the resin may, therefore, be restricted by steric
hindrance eﬀects due to aggregation. In alkaline media,
these aggregates represent ca. 10% (Table 1, fraction A)
of the mass of the crude extract.
The average molecular masses (Mr) and the size distri-
bution proﬁles of the crude extract and of fractions A
and E were determined by size-exclusion chromatogra-
phy (Fig. 2). Unlike proteins, monodisperse poly-
saccharides are rarely, if ever, found. Generally,
polysaccharides show chemical or physical heterogene-
ity. If the polymer is chemically homogeneous (com-
posed of identical repeating units) but physically
heterogeneous (whose molecular weight vary), it is
termed as polymolecular.38 This seems to be the case
of fractions A and E (Fig. 2): fractions collected at dif-
ferent stages of the elution and analysed for sugar com-
position revealed that the chemical composition of the
eluted polysaccharide is similar (data not shown). This
observation strongly suggests that the polysaccharide
is homogeneous. From the elution proﬁle of the crude
extract (Fig. 2), it seems to be a composition of fractions
A and E, since two peaks were observed along the curve
(as an estimate, fraction A accounts for ca. 15% and
fraction E, 85% of the total area of the curve). Fraction
A has a narrower Mr distribution proﬁle than fraction
E. Using dextrans as standards, the Mr values were cal-
culated to be 1.76MDa and 762kDa for fractions A and
E, respectively. Similar values were obtained by light-
scattering experiments. Pectins Mr ranges from 30 to0
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Figure 2. Elution proﬁle of the crude extract and fractions A and E on
a Sephacryl S-400 HR column. The crude extract, fractions A and E
(1mg/mL) were injected (500lL) into the column, and 0.1M NaOH
was used as the eluent. Fractions were collected and monitored by the
phenol–H2SO4 method. Vo––void volume.300kDa.39 However, higher molecular mass polysaccha-
rides have also been reported.40
The crude and fractions A and E were dispersed and
eluted in water and 0.1M NaOH. Size-exclusion chro-
matography showed that, at a higher pH, a broadening
of the crude extract elution proﬁle into the regions of
smaller molecular masses occurs. However, no signiﬁ-
cant changes were detected in either the elution proﬁles,
or the estimated Mr of fractions A and E. This was also
conﬁrmed by light scattering. The aggregation by poly-
saccharides such as pectins and arabinogalactans, even
when dissolved in 0.2M NaCl, has been described previ-
ously.41,42 These results suggest that further dispersion
of the aggregates from fraction A is not possible under
the experimental conditions used.
To identify the main type of glycoside linkages pre-
sent, the crude extract and fractions A and E were sub-
jected to methylation analysis (Table 2). Since the total
amount of terminal residues is coherent with the total
amount of branching points, all polysaccharides appear
to have been completely methylated.
FTIR analysis of the crude fraction showed that the
uronic acid content is from GalA only.29 As inferred
from the various linked GalA, Rha, Gal and a signiﬁ-
cant proportion of the Ara residues, the polysaccharide
in study is possibly an arabinan-rich pectic polysaccha-
ride. Ara represents 70–80% of the structural unit of
the polysaccharides, as calculated from the total
amount of Ara derivates (Table 2). However, according
to Table 1, Ara accounts only for 40–50% of the total
sugar content. As the overall recoveries of GalA were
very low (9–20%), that diﬀerence is due to this poor
recovery. For low %-sugar (such as the case with Rha
and Gal; Table 1), the variation in the total %-values
is not signiﬁcant.
The predominant peaks of the methylated products
were assigned to t-Araf:(1!5) > Araf:(1!3,5) > Araf:-
(1!2,3,5) > Araf. The high proportion of terminal resi-
dues, 90–95% of which are Ara, suggests a very low
mean degree of polymerisation (DP2, as estimated by
the ratio of total Ara residues to terminally linked Ara
residues). In addition to the high amounts of Ara (Table
1), the proportions of the main residues (30% of the total
Ara correspond to branching points though O-3 and
through O-2 and O-3; Table 2) suggests that the crude
extract and its fractions are composed by highly
branched arabinan side chains. In all cases, the polysac-
charides possess structural Ara moieties with highly
branched arabinan-rich pectic polysaccharides contain-
ing a 5)-Araf-(1! backbone. The average relative
proportions of the arabinosyl linkages was 3:2:1:1
for t-Araf:(1!5)-Araf:(1!3,5)-Araf:(1!2,3,5)-Araf,
comparable to the arabinan from cabbage.43
According to the linkage composition of the xylosil
residues, a highly branched xylan-type polysaccharide
may be present. As inferred from the average ratio of
Table 2. Partially methylated alditol acetates of the crude polysaccharide extract and fractions A and E, from P. dulcis seeds
Sugar Deduced linkage Sugar derivate mol (%)
Crude A E
Rha
2,4)-Rhap-(1! 3-Me rhamnitol 1.8 1.4 3.3
2,3,4)-Rhap-(1! Rhamnitol 0.3 0.3 0.4
Ara
Araf-(1! 2,3,5-Me3 arabinitol 38.6 36.3 30.5
5)-Araf-(1! 2,3-Me2 arabinitol 19.5 19.4 16.8
3)-Araf-(1! 2,5-Me2 arabinitol 0.6 0.5 1.3
3,5)-Araf-(1! 2-Me arabinitol 13.3 12.9 11.4
2,3,5)-Araf-(1! Arabinitol 10.7 13.3 8.8
Xyl
Xylp-(1! 2,3,4-Me2 xylitol 0.8 1.1 0.7
4)-Xylp-(1! 2,3-Me2 xylitol 1.5 3.2 2.8
2,4)-Xylp-(1! 3-Me xylitol 4.7 5.5 4.2
Gal
Galp-(1! 2,3,4,6-Me4 galactitol 1.3 0.9 2.1
3)-Galp-(1! 2,4,6-Me3 galactitol 1.4 1.5 2.0
3,4)-Galp-(1! 2,6-Me2 galactitol 0.6
4)-Galp-(1! 2,3,6-Me3 galactitol 2.9 2.2 8.5
3,6)-Galp-(1! 2,4-Me2 galactitol 0.4 0.3 0.4
2,4)-Galp-(1! 3,6-Me2 galactitol 0.3 0.3 0.5
GalA
4)-GalpA-(1! 2,3-Me2 galactitol(d) 1.7 1.0 4.8
GalA-(1! 2,3,4-Me3 galactitol(d) 0.4 0.7
Blank spaces = not detected, (d) = deuterated in C-6.
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mean degree of polymerisation is about 10.
As this extract was obtained following several alkaline
extractions, these xylan chains must be closely associ-
ated to the pectic polysaccharides, possibly as side
chains of a rhamnogalacturonan type I main chain. A
pectic polysaccharide with similar characteristics (both
structural and immunoactive) was described by Duan
et al.40 In this case, xylose is present in the side chains
of the pectin as an arabinoxylan. The presence of xylose
in the pectic polysaccharides was also referred by other
authors.44
3.2. Immunomodulatory activity assays
In order to investigate a putative immunomodulatory
eﬀect of the polysaccharides, the crude extract was
tested for the induction of activation on murine lympho-
cyte cells. Contaminant endotoxins were removed from
the polysaccharide preparations by aﬃnity chromato-
graphy in a polymyxin B coupled column. The culture
medium was also supplemented with this antibiotic, as
previously described.45,46 As shown in Figure 3, an in-
creased expression of the early activation marker
CD69 was observed on the surface of B-cells after 6h
in vitro stimulation of C57BL/6 mice spleen mononu-
clear cell cultures with 250lg/mL of the crude extract.
This in vitro B-cell stimulatory eﬀect was also observedin mononuclear spleen-cell cultures of the bacterial lipo-
polysaccharide (LPS)-tolerant C57BL/10 ScCr strain of
mice (Qureshi ST) (Fig. 3). These results indicate that
the crude extracts B-cell stimulatory eﬀect is not due
to contaminant endotoxin. Moreover, since C57BL/10
ScCr mice did not express toll-like receptor 4 (Qureshi
ST), the B lymphocyte activatory signal is thus inde-
pendent of this cell-surface receptor. A small fraction
of T-cells were also induced to express CD69, as ob-
served 6 h after the polysaccharide treatments of the
spleen mononuclear cells cultures of both C57BL/6
and C57BL/10 mice strains (Fig. 3).
In line with the observed increase of CD69 expression,
C57BL/6 mice spleen mononuclear cells cultured for
three days in the presence of 250lg/mL of the crude
extract exhibited a mild proliferative response (Fig.
4A). This proliferative eﬀect was not detected when
2- to 10-fold lower doses of crude extract were used
to stimulate the cell cultures (data not shown). This
stimulatory eﬀect of the crude extract on murine
spleen lymphocytes was also indicated by the increased
surface expression of CD25 (a lymphocyte activation
marker expressed later than CD69) observed on
B-cells (IgM+), in these mononuclear cell cultures
(Fig. 4B).
Interestingly, the in vitro stimulation of cultures
of pure macrophage cells with the crude extract did not
induce the production of either TNF or IL-10, two
Figure 3. In vitro lymphocyte stimulatory eﬀect of crude extract. Flow cytometric analysis of CD69 expression on the surface of C57/BL6 or C57BL/
10 ScCr mice B (IgM+) and T (CD3+) cells in spleen mononuclear cell cultures after 6h incubation with 250lg/mL of crude extract (crude) or medium
alone (RPMI). Numbers represent the percentage of CD69-expressing cells on the indicated lymphocyte populations and are the means plus one SD
of three samples per group of a representative experiment repeated four times. In this and in following Figures 4, 6 and 7 statistically signiﬁcant
diﬀerences between control and crude extract-treated groups (**p < 0.01 or *p < 0.05) are indicated.
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even when a high dose (2500lg/mL) of crude extract
was used (Fig. 5). Stimulation with 25 or 250lg/mL of
crude extract also did not induce the production of these
two cytokines (data not shown). This lack of TNF pro-
duction is in accordance with the lack of detectable
cytotoxicity, observed in mononuclear cell cultures
stimulated with the crude extract within the range of
concentrations used in these experiments. Also, lack of
TNF induction further excludes the presence of contam-
inating endotoxin on the polysaccharide samples.
A lymphocyte stimulatory eﬀect, as measured by the
induction of CD69 expression, was also observed in
vitro and in vivo with fractions A and E. Thus, an
increase in CD69 expression was observed on the sur-
face of B-cells and to a lesser extent on T-cells, 6h after
in vitro treatment of C57BL/6 spleen mononuclear cells
cultures with 125g/mL of fractions A or E (Fig. 6). As
also shown in Figure 6, fraction E was a more potent
B-cell stimulator than fraction A.
The lymphocyte stimulatory capacity of fraction E, as
well as that of the crude extract, was also studied in vivo,
and an increased CD69 expression was observed in the
surface of splenic B-cells 6h after i.p. treatment ofC57BL/6 mice with 250lg of fraction E or crude extract,
as compared to PBS-inoculated controls. The in vivo B-
cell stimulatory eﬀect was more pronounced in fraction
E than in crude extract-treated mice (Fig 7). In contrast
with the in vitro treatments, the expression of CD69 on
the surface of T-cells was not increased in the crude
extract-treated mice with the dose used, but was
detected in fraction E-treated mice as also shown in
Figure 7.
Several other polysaccharides have previously been
shown to induce the activation of B-cells and/or T-cells,
namely, a pectic polysaccharide from the roots of the
medicinal herb Bupleurum falcatum L.,27 an inulin-type
polysaccharide isolated from the radix of Platycodon
grandiﬂorum or Angelan, a pectic polysaccharide
isolated from A. gigas Nakai that was reported to
directly activate macrophages and B-cells, but not
T-cells.49–51
Putative immunomodulatory applications of the poly-
saccharide fractions studied here will need further inves-
tigation. An adjuvant eﬀect on immunisation against
proteinaceous antigens could be a possibility. Alterna-
tively, since increased susceptibility to infections or
autoimmune pathology often arise as a consequence of
Figure 4. Lymphocyte stimulatory eﬀect of crude extract on three-days spleen mononuclear cell cultures. (A) Proliferative index evaluated with the
MTT proliferation assay of C57BL/6 spleen mononuclear cells cultures stimulated with medium alone (RPMI), LPS (5lg/mL), Concanavalin A
(5lg/mL) or crude extract (250lg/mL). (B) Flow cytometric analysis of CD25 expression on the surface of C57/BL6 B (IgM+) and T (CD3+) cells in
spleen mononuclear cell cultures after incubation for 3days with 250lg/mL of crude extract (crude) or medium alone (RPMI). Numbers represent
the percentage of CD25-expressing cells on the indicated lymphocyte populations and are means plus one SD of three samples per group of a
representative experiment repeated three times.
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immunodeﬁciencies,52,53 including those related to age-
ing,54,55 it is tempting to hypothesise that due to their
B-cell stimulatory eﬀect, crude extract or fractions E
or A could be of potential preventive or therapeutic
application in these situations. A beneﬁcial eﬀect on im-
mune-mediated response against Staphylococcus aureus
and Eimeria vermiformis was previously reported for
another polysaccharide of plant origin in a murine
model.21 Interestingly, the polysaccharide used in the
present report was unable to stimulate murine macro-
phages to produce the pro-inﬂammatory cytokine
TNF. This could be of relevance regarding putativeimmunomodulatory applications of this product since
the deleterious eﬀects of an excessive production of
TNF are well known as epitomised in septic shock.56
Also, although less marked than on B-cells, a stimula-
tory eﬀect of the crude extract and fractions E and A
was detected on a small fraction of T-cells. It will thus
be of interest to characterize the surface and functional
phenotype of these responding cells.
The search for novel compounds that show immuno-
modulatory activities––without severe side eﬀects to the
host––has become an important goal of research in the
biomedical sciences. Several studies have been carried
out with polysaccharides isolated from plant sources.
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Figure 5. TNF and IL-10 production by macrophage cells stimulated
with crude extract. TNF (A) and IL-10 (B) concentrations in culture-
supernatants of pure macrophage cells. Cell-culture supernatants were
harvested at the indicated time points after stimulation with medium
alone (open bars), 5lg/mL of LPS (closed bars) or with 2500lg/mL of
crude extract (shaded bar). Results are the means plus one SD of
triplicate samples and representative of an experiment repeated
twice.
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Figure 6. In vitro lymphocyte stimulatory eﬀect of fraction A and E.
Percentage of CD69-expressing B (IgM+)-cells (open bars) or T
(CD3+)-cells (closed bars) cells in C57BL/6 mice spleen mononuclear
cells cultures stimulated for 6h with medium alone (RPMI), 5lg/mL of
LPS (LPS) or with 125lg/mL of either fraction A (A) or fraction E (E).
Numbers represent the percentage of CD69-expressing cells among the
indicated lymphocyte populations and are means plus one SD of
triplicate samples of a representative experiment repeated three
times.
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The potential usefulness of immunomodulating polysac-charides in the treatment of some diseases has been dem-
onstrated in preclinical and clinical studies. While the
activity of some of these polysaccharides has been
known over the last decades, the lack of further puriﬁca-
tion and of comprehensive structural and mechanistic
information has limited the eﬀort to study their poten-
tial for clinical use.
Data gathered from the research presented herein, jus-
tiﬁes the interest for future work that will include a more
detailed structural characterization of the Ara-rich pec-
tic polysaccharides from the CWM of P. dulcis. In addi-
tion, several bioactivities will be tested: anti-tumour,
immunostimulating, anti-complementary, anti-inﬂam-
matory, reticuloendothelial system-potentiating, anti-
coagulant and ﬁbrinogenic, to name a few. These studies
will allow a better understanding of the mechanism and
structural aspects of the polysaccharides that modulate
the potential bioactivities.
The scientiﬁc literature shows that the tailoring of the
polysaccharides with enzymes further enhances the
bioactivity of the polysaccharides. Future work will
also focus on the partial enzymatic degradation of
the polysaccharides and assessment of inﬂuence of
the enzymatic treatment on the bioactivities tested.
This may also shed light on to the minimal struc-
ture of the polysaccharide responsible for a given
bioactivity.
The possibility of using polysaccharides alone or in
conjunction with other already existing chemical alter-
natives would be of great interest in therapeutic applica-
tions and will also be investigated.4. Conclusions
An arabinan-rich pectic polysaccharide, with an appar-
ent molecular mass 762kDa was isolated from P. dulcis
seed cell walls. The highly branched arabinan moiety
contains a (1!5)-Araf backbone. The average rela-
tive proportions of the arabinosyl linkages was 3:2:1:1
for t-Araf:(1!5)-Araf:(1!3,5)-Araf:(1!3,5)-Araf.
Immunomodulatory activity assays showed that the
crude extract stimulate the surface expression of the
lymphocyte activation markers CD69 and CD25 on
the surface of B-cells and of CD69 in the surface of T-
cells, and also mononuclear cell-culture proliferation.
The lymphocyte stimulatory eﬀect as evaluated by
CD69 expression was also obtained with the acidic frac-
tion (E) and with the neutral fraction (A). In the range
of concentrations used in these experiments, no evidence
of cytotoxic eﬀects induced by the polysaccharide frac-
tions was found.
Further research on the structure and relationship be-
tween structure and the immunobiologic activities of the
puriﬁed polysaccharides from P. dulcis seed is required
and is currently in progress.
Figure 7. In vivo lymphocyte stimulatory eﬀect of fraction E or crude extract. Flow cytometric analysis of CD69 expression on the surface of spleen
B (IgM+) and T (CD3+) cells of C57/BL6 mice 6h after inoculation i.p. with 0.25mL of PBS or 0.25mL of PBS containing 250lg of crude extract or
fraction E as indicated. Numbers represent the percentage of CD69-expressing cells among the indicated lymphocyte populations. These are means
plus one SD of four mice per group and are a representative experiment repeated twice.
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